IGF1 and cancer: The anti-cancer effect of metformin results from its ability to interfere with several biological processes including: inhibition of tumor cell proliferation by activation of adenosine monophosphate-activated protein kinase [36]; regulation of insulin/insulin-like growth factor 1 axis activity [37]; induction of tumor cell cycle arrest and apoptosis [38]; and regulation of energy metabolism [39].